Doxycycline Oral Suspension Shortage
Last Updated: March 22, 2024
Status: Current
Products Affected - Description
-
- Vibramycin Monohydrate oral powder for suspension, Pfizer, 25 mg/5 mL, 60 mL bottle, NDC 00069-0970-65 - discontinued
- Doxycycline monohydrate oral powder for suspension, Cipla USA, 25 mg/5 mL, 60 mL bottle, NDC 69097-0228-43 - discontinued
Reason for the Shortage
-
- Chartwell launched doxycycline monohydrate powder for oral suspension in November 2023.
- Cipla discontinued doxycycline monohydrate powder for oral suspension in 2021.
- Pfizer had Vibramycin Calcium oral suspension on shortage due to manufacturing delay.
- Pfizer discontinued Vibramycin Monohydrate powder for oral suspension in November 2021.
- Lupin has doxycycline monohydrate powder for oral suspension available.
Available Products
-
- Vibramycin Calcium oral suspension, Pfizer, 50 mg/5 mL, 473 mL bottle, NDC 00069-0971-95
- Doxycycline monohydrate oral powder for suspension, Chartwell, 25 mg/5 mL, 60 mL bottle, NDC 62135-0417-46
- Doxycycline monohydrate oral powder for suspension, Lupin, 25 mg/5 mL, 60 mL bottle, NDC 68180-0657-01
Updated
Updated March 22, 2024 by Leslie Jensen, PharmD, Drug Information Specialist. Created November 16, 2021 by Leslie Jensen, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.